Summit Investment Advisors »

Lenz Therapeutics shares owned by Summit Investment Advisors

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Summit Investment Advisors from 13F filings

Historical chart of Summit Investment Advisors investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Summit Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $21k 1.2k 17.29
2024-03-31 $7.4k 331 22.30

More positions owned by Summit Investment Advisors

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Ishares Tr Etf (IVV)
Vanguard Europe Pacific ETF (VEA)
Alphabet Inc Class C cs (GOOG)
Vanguard S&p 500 Etf idx (VOO)
iShares Lehman Aggregate Bond (AGG)
Broadcom (AVGO)
Facebook Inc cl a (META)
Spdr Ser Tr Etf (ONEV)
Vanguard Total Bond Market ETF (BND)
iShares S&P 500 Growth Index (IVW)
Alphabet Inc Class A cs (GOOGL)

View all positions for Summit Investment Advisors

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
EcoR1 Capital
Samsara BioCapital
72 Investment Holdings
BlackRock
Vanguard Group
Point72 Asset Management
Tang Capital Management
Geode Capital Management
Alyeska Investment Group
State Street Corporation
Ikarian Capital
Board of Trustees of The Leland Stanford Junior University
Wealth Enhancement Advisory Services

View all funds holding Lenz Therapeutics